Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

08-20-2021 | Ultra-rapid lispro | News

approvalsWatch

FDA approves ultra-rapid lispro for use in pumps

Author: Eleanor McDermid

print
PRINT
insite
SEARCH

medwireNews: Ultra-rapid lispro may now be used in insulin pumps by people with type 1 diabetes in the USA following FDA approval.

This decision in based on the results of the PRONTO-PUMP-2 trial, in which pump users had significantly lower postprandial glucose levels with ultra-rapid lispro versus lispro, and spent significantly less time in hypoglycemia overall.

The alterations to the medication label also include the warning that insulin pump or infusion set malfunction can lead rapidly to ketoacidosis.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

print
PRINT

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Related content

07-23-2020 | Insulin lispro | News

PRONTO-T2D: ‘Good glycemic control’ with ultra-rapid insulin lispro

01-07-2020 | Insulin pumps | Highlight | News

Insulin pumps may help stabilize glucose levels over the long term

05-29-2019 | Insulin pumps | News

Real-world data confirm benefits of ‘pump-suspend’ technology in diabetes
Image Credits